Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,950 shares at $439.11 ($3.1M) on 2024-05-30, disclosed to the SEC on 2024-06-03.
Scheduled sale ($3.1M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $439.11 | 2,350 | $1.0M | 33.7% |
| 2 | $439.11 | 2,350 | $1.0M | 33.7% |
| 3 | $445.00 | 2,250 | $1.0M | 32.7% |
| Total | $441.02 avg | 6,950 | $3.1M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |